Metoclopramide “medical Valley”

Metoclopramide, the active ingredient in Metoclopramide “medical Valley”, is a dopamine D2 receptor antagonist presented as an oral dosage form for oral use. It is employed to relieve nausea, vomiting and to improve gastric emptying in patients with gastroparesis or reflux disease.

GNH USA supplies Metoclopramide “medical Valley” as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is a prokinetic and anti‑emetic agent that acts on the gastrointestinal tract and the chemoreceptor trigger zone. - Nausea and vomiting: reduces episodes of acute and chemotherapy‑induced nausea. - Gastroparesis: enhances gastric motility to improve stomach emptying. - Gastroesophageal reflux disease: decreases reflux episodes by promoting gastric clearance.

Metoclopramide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: inner sense of agitation or inability to stay still. - Diarrhea: loose, watery stools. - Dry mouth: reduced salivation. - Headache: mild to moderate head pain. - Dystonia (especially in young adults): involuntary muscle contractions.

Serious or Rare Side Effects: - Extrapyramidal symptoms: severe movement disorders such as Parkinsonism. - Tardive dyskinesia: persistent involuntary facial movements with long‑term use. - Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and rigidity. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Cardiac arrhythmias: irregular heartbeats in susceptible individuals.

Before prescribing Metoclopramide, clinicians should consider several safety aspects. - Contraindication: avoid in patients with known hypersensitivity to metoclopramide. - Neurological disorders: use cautiously in individuals with Parkinson's disease or seizure disorders. - Pregnancy: assess risk versus benefit; data are limited. - Breastfeeding: consider potential drug transfer to infant. - Elderly patients: monitor closely for extrapyramidal effects. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Metoclopramide can alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): additive extrapyramidal effects. - CYP2D6 substrates (e.g., codeine): reduced analgesic conversion.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): enhanced sedation. - Anticholinergic drugs (e.g., atropine): may diminish pro‑kinetic effect. - Digoxin: possible increase in serum levels. - Antihistamines: may counteract anti‑emetic action.